Evidence map›Paper›PMID 42327181›Full record

ArticlebioRxiv : the preprint server for biology2026

An AI-Powered Trisomy 21 Research Assistant.

Sutanu Nandi, Zenitha Sundararajan, Marc Subirana-Granés, Joaquin M Espinosa, Milton Pividori, Kelly D Sullivan, Matthew D Galbraith, James C Costello

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sutanu NandiDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0009-0001-5887-999X
Zenitha SundararajanLinda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Marc Subirana-GranésDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Joaquin M EspinosaDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-9048-1941
Milton PividoriDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kelly D SullivanLinda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Matthew D GalbraithDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
James C CostelloDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-3158-9682

Funding

User-ready tools and scalable workflows for INCLUDE datasets in the cloud: advancing brain imaging data management and analyticsU2CHL156291 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Adam Cain Resnick · 2020 to 2026
$43.8M
Novel computational strategies to deconvolute co-occurring conditions in Down syndromeR01HD109765 · NICHD · UNIVERSITY OF COLORADO DENVER · PI James Christopher Costello, Casey S Greene · 2022 to 2026
$4.1M
Computational approaches to characterize heterogeneity and improve risk stratification in complex disease phenotypesR00HG011898 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI PIVIDORI, MILTON · 2023 to 2025
$747k
Computational approaches to characterize heterogeneity and improve risk stratification in complex disease phenotypesK99HG011898 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI PIVIDORI, MILTON · 2022 to 2022
$121k
NHGRI NIH HHS K99 HG011898NHGRI NIH HHS R00 HG011898NHLBI NIH HHS U2C HL156291NICHD NIH HHS R01 HD109765
6 · The paper itself

Abstract

Down syndrome, caused by trisomy 21, increases the risk of diverse co-occurring conditions. With more than 34,000 related publications indexed in PubMed as of early 2026, keeping pace with this expanding literature is challenging. While general-purpose large language models are widely used for information retrieval, they often rely on broad training data rather than specific evidence. Retrieval-augmented generation (RAG) improves rigor and reliability of responses by linking model outputs to source texts. In research, source texts are peer-reviewed articles. Standard implementations treat all manuscript sections equally, allowing background text to rank as highly as experimental results. To focus model outputs on experimentally supported responses, we developed the T21 Research Assistant, a section-aware RAG system that prioritizes Results sections to ground responses in primary experimental evidence. The system draws exclusively from 1,789 open-access Down syndrome publications from PubMed Central, including 327 NIH INCLUDE-funded studies, and uses a multistage pipeline for query validation, retrieval, reranking, synthesis, and citation verification. Built on NVIDIA Nemotron models, it generates structured, cited responses. Evaluation using expert-curated questions demonstrated strong performance, achieving a BERTScore F1 of 0.712 and recall of 0.758, comparable to or exceeding leading proprietary and open-source models. T21 Research Assistant is available at: https://bioinformatics.cuanschutz.edu/t21-res-assi/.

Identifiers

PMID42327181
PMCPMC13278113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.